Literature DB >> 19828315

Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Jouni Vesa1, Hailing Su, Giles D Watts, Sabine Krause, Maggie C Walter, Barbara Martin, Charles Smith, Douglas C Wallace, Virginia E Kimonis.   

Abstract

Inclusion body myopathy associated with Paget's disease and frontotemporal dementia (IBMPFD) is caused by mutations in the valosin containing protein (VCP) gene. The disease is associated with progressive proximal muscle weakness, inclusions and vacuoles in muscle fibers, malfunction in the bone remodeling process resulting in Paget's disease, and premature frontotemporal dementia. VCP is involved in several cellular processes related to the endoplasmic reticulum associated degradation of proteins. To understand the pathological mechanisms underlying the myopathy in IBMPFD, we have studied the cellular consequences of VCP mutations in human primary myoblasts. Our results revealed that patients' myoblasts accumulate large vacuoles. Lysosomal membrane proteins Lamp1 and Lamp2 show increased molecular weights in patients' myoblasts due to differential N-glycosylation. Additionally, mutant myoblasts show increased autophagy when cultured in the absence of nutrients, as well as defective cell fusion and increased apoptosis. Our results elucidate that VCP mutations result in disturbances in several cellular processes, which will help us in the understanding of the pathological mechanisms resulting in muscle weakness and other features of VCP associated disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828315      PMCID: PMC2782446          DOI: 10.1016/j.nmd.2009.08.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  40 in total

Review 1.  Forming a multinucleated cell: molecules that regulate myoblast fusion.

Authors:  Valerie Horsley; Grace K Pavlath
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

2.  Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease).

Authors:  J A Lobrinus; D F Schorderet; M Payot; X Jeanrenaud; A Bottani; A Superti-Furga; J Schlaepfer; M Fromer; P-Y Jeannet
Journal:  Neuromuscul Disord       Date:  2005-04       Impact factor: 4.296

3.  Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.

Authors:  Qishan Wang; Jnanankur Bag
Journal:  Biochem Biophys Res Commun       Date:  2005-12-21       Impact factor: 3.575

Review 4.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

5.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.

Authors:  M Hirabayashi; K Inoue; K Tanaka; K Nakadate; Y Ohsawa; Y Kamei; A H Popiel; A Sinohara; A Iwamatsu; Y Kimura; Y Uchiyama; S Hori; A Kakizuka
Journal:  Cell Death Differ       Date:  2001-10       Impact factor: 15.828

7.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

8.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Authors:  I Nishino; J Fu; K Tanji; T Yamada; S Shimojo; T Koori; M Mora; J E Riggs; S J Oh; Y Koga; C M Sue; A Yamamoto; N Murakami; S Shanske; E Byrne; E Bonilla; I Nonaka; S DiMauro; M Hirano
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

9.  Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro.

Authors:  C Rabouille; H Kondo; R Newman; N Hui; P Freemont; G Warren
Journal:  Cell       Date:  1998-03-06       Impact factor: 41.582

Review 10.  Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle.

Authors:  May Christine Malicdan; Satoru Noguchi; Ikuya Nonaka; Paul Saftig; Ichizo Nishino
Journal:  Neuromuscul Disord       Date:  2008-05-27       Impact factor: 4.296

View more
  40 in total

1.  Global gene profiling of VCP-associated inclusion body myopathy.

Authors:  Angèle Nalbandian; Svetlana Ghimbovschi; Shlomit Radom-Aizik; Eric Dec; Jouni Vesa; Barbara Martin; Susan Knoblach; Charles Smith; Eric Hoffman; Virginia E Kimonis
Journal:  Clin Transl Sci       Date:  2012-04-04       Impact factor: 4.689

2.  A non-canonical role of the p97 complex in RIG-I antiviral signaling.

Authors:  Qian Hao; Shi Jiao; Zhubing Shi; Chuanchuan Li; Xia Meng; Zhen Zhang; Yanyan Wang; Xiaomin Song; Wenjia Wang; Rongguang Zhang; Yun Zhao; Catherine C L Wong; Zhaocai Zhou
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

3.  In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Arianna Gomez; Naomi Walker; Hailing Su; Andrew Dunnigan; Marilyn Chwa; Jouni Vesa; M C Kenney; Virginia E Kimonis
Journal:  Mitochondrion       Date:  2015-02-25       Impact factor: 4.160

4.  Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.

Authors:  Wai Kwan Tang; Di Xia
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

5.  The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.

Authors:  Carlos J Rodriguez-Ortiz; Julio C Flores; Joanna A Valenzuela; Gema J Rodriguez; Joannee Zumkehr; Diana N Tran; Virginia E Kimonis; Masashi Kitazawa
Journal:  Am J Pathol       Date:  2016-04-20       Impact factor: 4.307

6.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

Review 7.  Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code.

Authors:  Philippe Cloutier; Benoit Coulombe
Journal:  Biochim Biophys Acta       Date:  2013-02-28

8.  Cytokine profiling in patients with VCP-associated disease.

Authors:  Eric Dec; Prachi Rana; Veeral Katheria; Rachel Dec; Manaswitha Khare; Angèle Nalbandian; Szu-Yun Leu; Shlomit Radom-Aizik; Katrina Llewellyn; Lbachir BenMohamed; Frank Zaldivar; Virginia Kimonis
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

9.  Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Authors:  Christopher Grunseich; Kristen Zukosky; Ilona R Kats; Laboni Ghosh; George G Harmison; Laura C Bott; Carlo Rinaldi; Ke-lian Chen; Guibin Chen; Manfred Boehm; Kenneth H Fischbeck
Journal:  Neurobiol Dis       Date:  2014-06-09       Impact factor: 5.996

10.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.